The Scientist: Special straw may be reliable cure for hiccups
June 22, 2021
Ali Seifi, MD, FNCS, FCCM, an associate professor in the Department of Neurosurgery, is quoted in this story in The Scientist. Read story
San Antonio Express-News: ‘Not done’: Delta coronavirus variant a threat to unvaccinated, partially vaccinated San Antonians
June 17, 2021
Dr. Jason Bowling, Infectious Diseases, and Dr. Ruth Berggren, Infectious Diseases/Center for Medical Humanities and Ethics, spoke to the San Antonio Express-News about the Delta coronavirus variant being a threat to the unvaccinated, partially vaccinated San Antonians (subscription needed). Read the story.
Yahoo! Finance: Breaking down the threat of the COVID-19 delta variant
June 17, 2021
In this video, Dr. Owais Durrani, Emergency Medicine resident physician, discusses the threat of the COVID-19 delta variant in Yahoo! Finance. Watch here.
WRadio: La vacuna Janssen tiene una sola dosis: infectólogo
June 15, 2021
Dr. Jose Cadena Zuluaga, Infectious Diseases, spoke on a Colombia radio program regarding the advantages of Johnson & Johnson’s Janssen vaccine arriving in Colombia. The advantages include that it has only one dose and does not require refrigeration as the other vaccines. Listen here.
Texas Public Radio: New vaccine alleged to have 100% efficacy against original COVID-19 strain
June 15, 2021
This Texas Public Radio news brief is about the biotechnology company Novavax releasing Phase 3 clinical trial results. UT Health San Antonio collaborated with University Health as part of the international COVID-19 Prevention Network and enrolled 176 Novavax clinical trial participants in San Antonio for the Phase 3 study, which is called PREVENT-19. Read the story.
San Antonio Business Journal: Alamo City research contributes to potential new COVID vaccine
June 15, 2021
Dr. Barbara Taylor, Infectious Diseases, and the great work of the Novavax research team of UT Health San Antonio and University Health, are featured in the San Antonio Business Journal. The local site of the international clinical trial by the COVID-19 Prevention Network enrolled more than 175 participants. Read the story.